Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

GreenBox POS (NASDAQ: GBOX) Surpasses Projections with Record 2021 Processing Volume of $1.95 Billion; Appoints Seasoned Cross-Functional Management Expert as Chief Operating Officer

GreenBox POS has released preliminary unaudited 2021 results wherein its revenue and transaction volume grew by more than 200% and 800%, respectively The company’s processing volume outstripped its initial projections of $1.85 billion GreenBox recorded a transaction volume of $1.95 billion in 2021, while its revenues increased to at least $26 million GreenBox recently appointed […]

Nemaura Medical Inc. (NASDAQ: NMRD) Seeks to Provide Non-Invasive Glucose Monitoring Solutions to Millions of Patients Worldwide

Over 420 million people around the globe currently have diabetes, with the figure set to rise by 55% over the next 25 years Millions of patients required to measure their blood glucose levels daily to accurately determine their insulin dosage amounts Nemaura Medical has launched two constant glucose monitoring solutions – the SugarBEAT(R) device as […]

Growth of Plant-based Meat Market Underscores Value of PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) Distribution Network Buildup

Since the advent of the COVID-19 pandemic, plant-based meat sales have grown — initially 63 percent over 2019 levels during panic buying and now at a more stable 30 percent rate PlantX Life’s e-commerce and plant-based community sustaining presence online serves plant-based lifestyle customers with a growing one-stop shopping operation The company’s varied educational efforts […]

Eat Well Investment Group Inc. (CSE: EWG) (OTC: EWGFF) Podcast Interview Shines Spotlight on Emerging Company’s Ambitious Growth Strategy

Nutritious plant-based food producer for people and pets Eat Well Investment Group Inc. is rapidly growing, reporting nearly $60 million in revenue in Canadian dollars last year The company essentially formed last year, but has been decades in the making, permitting it a newcomer position but with an experienced leadership CEO Marc Aneed appeared recently […]

Amid Growing Interest in Cryptocurrencies, LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF) Roots Growth in Lightning Network Success in 2021

Arizona and Wyoming have introduced proposals for their states to introduce tax payments by digital currency India is working toward incorporating a digital rupee, including the implementation of a 30% tax on income earned from digital currency investments to begin during 2022 LQwD’s growth is centered on the success of the Lightning Network and the […]

Focused on Pillars of Success for 2022, Friendable Inc. (FDBL) Disrupts Traditional Music Industry with “Anti-Label” Opportunities

Friendable recorded a 14,000% YOY increase in revenue (more than $20,000 in January 2022) and more than 8,000% YOY growth of its Fan Pass Live artist database, topping 105,000 artists Fan Pass Live platform offers the only all-inclusive option for independent artists, from live performances and merchandise creation (and sales) to music recording and distribution […]

Following Successful Sildenafil Animal Study, Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Plans for More Studies in 2022

Lexaria’s animal study could be the first step to developing faster and better acting sildenafil oral formulations The most prominent study for Lexaria in 2022 is HYPER-H21-4, investigating patented DehydraTECH(TM)-CBD for hypertension and heart disease Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, recently announced positive findings in an animal study that […]

Identified Psilocybin and MDMA Supplier, New Addition Strengthens Mydecine Innovations Group Inc.’s (NEO: MYCO) (OTC: MYCOF) Board Experience

Biotechnology company Mydecine Innovations Group is devoted to advancing the use of psychedelics for the treatment of mental illnesses and addiction Mydecine has necessary license to provide psilocybin and MDMA under Canada’s SAP program, which allows medical providers to request otherwise unavailable drug substances for the treatment of patients who have not seen success with […]

 

From Our Blog

Federal Permits to Advance Ambler Access Project Strengthen Alaska’s Role in Domestic Supply Chain of Critical Minerals

November 14, 2025

This article has been disseminated on behalf of  Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) and may include paid advertising. As the global demand for metals surges and the U.S. government turns to Alaska for secure critical mineral supply, a renewed sense of purpose is taking place in America’s Last Frontier. With prices rising […]

Rotate your device 90° to view site.